Clearlake explores Symplr stake sale, seeking $2bn valuation

The Santa Monica buyout firm bought Symplr in 2018 in a transaction valuing the healthcare software company at about $550 million.

22 July 2020•2 mins read
Levine Leichtman Partners, healthcare, Capsa, Therapeutic Research Center, private equity, merger, M&A
LinkedInXEmail
LinkedInXEmail

Related articles